MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors

NCT06030869 · clinicaltrials.gov ↗

UNKNOWN

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Refractory Solid Tumors
Next Generation Sequencing

Sponsor

Tianjin Medical University Second Hospital